Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii

American Journal of Infection Control

Volumn 30, Issue 7, 2002, Pages 386-390

  Mahgoub, Siham ^a   Ahmed, Jimmie ^b   Glatt, Aaron E ^a,b,c  

^a Division of Infectious Diseases   (United States)

^b Department of Infection Control ^*  (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; IMIPENEM; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; COMORBIDITY; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; RISK FACTOR; TRACHEOSTOMY;

EID: 0036846426     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1067/mic.2002.122648     Document Type: Article

References (12)

1. Allen DM, Hartman BJ. Acinetobacter Species. Principles and Practice of Infectious Diseases. Mandell GL, Bennett JE, Dolin R, editors. Churchill Livingstone; 2000. p. 2339-43.
2. Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, et al. Mortality and the increased length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med 1999;27(9):1794-8.
3. Lortholary O, Fagon JY, Hoi AB, et al. Nosocomial acquisition of mutiresistant Acinetobacter baumannii: Risk factors and prognosis. Clin Infect Dis 1995;20:790-6.
4. Mahgoub S, Ahmed J, Glatt AE. Completely resistant Acinetobacter baumannii species. Infect Control Hosp Edidemiol 2002;23:477-9.
5. Okpara AU, Maswoswe JJ. Emergence of multidrug-resistant isolates of Acinetobacter baumannii. Am J Hosp Pharm 1994;51(21):2671-5.
6. Koeleman JG, Parlevliet GA, Dijkshoorn L, et al. Nosocomial outbreak of multi-resistant Acinetobacter baumannii on a surgical ward: Epidemiology and risk factors for acquisition. J Hosp Infect 1997;37(2):113-23.
7. Baraibar J, Correa H, Mariscal D, et al. Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia. Chest 1997;112:1050-4.
8. Mulin B, Talon D, Viel JF, et al. Risk factors for nosocomial colonization with multiresistant Acinetobacter baumanni. Eur J Clin Microbiol Infect Dis 1995;14(7):569-76.
9. Villers D, Espaze E, Coste-Burel M, et al. Nosocomial Acinetobacter baumannii infections: Microbiological and clinical epidemiology. Ann Intern Med 1998;129(3):182-9.
10. Manikal VM, Landman D, Saurina G, et al. Endemic carbapenem-resistant species in Brooklyn, New York: Citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 2000;31:101-6.
11. Husni RN, Goldstein LS, Arroliga AC, et al. Risk factors for an outbreak of multi-drug resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 1999;115:1378-82.
12. Go ES, Urban C, Burns J, et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 1994:344:1329-32.